When even the most highly trained surgeons perform procedures on the retina—one of the smallest, most delicate parts of the ...
Cataracts, dry eyes, glaucoma and other eye problems become more common with age. But these can be treated — and sometimes ...
The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic macular edema (DME) who have previously responded to at least 2 ...
it is possible that patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of pharmacologic therapy, including intravitreal injections of anti-VEGF ...
The Food and Drug Administration (FDA) has expanded the labeling for Izervay™ (avacincaptad pegol intravitreal solution) to include longer-term ...
10, 2024 — In a single IV injection, a gene therapy targeting ... 2024 — Adults with hemophilia B saw their number of bleeding episodes drop by an average of 71 percent after a single infusion ...
The introduction of anti-VEGF agents has revolutionized the field of medical retina care by reducing rates of vision loss and ...
Researchers used mice with nine different genetic backgrounds to identify factors influencing eye aging, paving the way for eye-based diagnostics for neurodegenerative diseases.
Oculomics, or the study of the retina using AI, emerged as a groundbreaking field with potential to detect things like ...
Researchers from London's Moorfields Eye Hospital, biotech firm MeiraGTx and University College London have demonstrated that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback